Response assessment of somatostatin receptor targeted radioligand therapies for progressive intracranial meningioma

被引：10
|
作者：
Muether, Michael [1 ]
Roll, Wolfgang [2 ]
Brokinkel, Benjamin [1 ]
Zinnhardt, Bastian [3 ]
Sporns, Peter B. [4 ]
Seifert, Robert [2 ]
Schafers, Michael [3 ]
Weckesser, Matthias [2 ]
Stegger, Lars [2 ]
Stummer, Walter [1 ]
Rahbar, Kambiz [2 ]
机构：
[1] Univ Hosp Munster, Dept Neurosurg, Munster, Germany
[2] Univ Hosp Munster, Dept Nucl Med, Munster, Germany
[3] WWU, European Inst Mol Imaging, Munster, Germany
[4] Univ Hosp Munster, Inst Clin Radiol, Munster, Germany
来源：
NUKLEARMEDIZIN-NUCLEAR MEDICINE | 2020年 / 59卷 / 05期
关键词：
Lu-177-DOTATATE; PRRT; meningioma; RADIONUCLIDE THERAPY; PET; Y-90-DOTATOC; GUIDELINES; RECURRENT; EANM;
D O I：
10.1055/a-1200-0989
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Zusammenfassung
引用
收藏
页码：348 / 355
页数：8
相关论文
共 50 条
  • [41] ASSESSMENT OF THE BETA-ADRENERGIC-RECEPTOR PATHWAY IN THE INTACT FAILING HUMAN-HEART - PROGRESSIVE RECEPTOR DOWN-REGULATION AND SUBSENSITIVITY TO AGONIST RESPONSE
    FOWLER, MB
    LASER, JA
    HOPKINS, GL
    MINOBE, W
    BRISTOW, MR
    CIRCULATION, 1986, 74 (06) : 1290 - 1302
  • [42] Assessment of γ-H2AX and 53BP1 Foci in Peripheral Blood Lymphocytes to Predict Subclinical Hematotoxicity and Response in Somatostatin Receptor-Targeted Radionuclide Therapy for Advanced Gastroenteropancreatic Neuroendocrine Tumors
    Derlin, Thorsten
    Bogdanova, Natalia
    Ohlendorf, Fiona
    Ramachandran, Dhanya
    Werner, Rudolf A.
    Ross, Tobias L.
    Christiansen, Hans
    Bengel, Frank M.
    Henkenberens, Christoph
    CANCERS, 2021, 13 (07)
  • [43] Theranostics of retro-orbital metastases from neuroendocrine tumors: response assessment using somatostatin receptor PET/CT and improvement in symptoms using peptide receptor radionuclide therapy
    Kulkarni, H. R.
    Heinle, I.
    Carreras, C.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S331 - S331
  • [44] Impressive Response to TANDEM Peptide Receptor Radionuclide Therapy with 177Lu/225AcDOTA-LM3 Somatostatin Receptor Antagonist in a Patient with Therapy-Refractory, Rapidly Progressive Neuroendocrine Neoplasm of the Pancreas
    Perrone, Elisabetta
    Ghai, Kriti
    Eismant, Aleksandr
    Andreassen, Mikkel
    Langer, Seppo W.
    Knigge, Ulrich
    Kjaer, Andreas
    Baum, Richard P.
    DIAGNOSTICS, 2024, 14 (09)
  • [45] CT response assessment combining reduction in both size and arterial phase density correlates with time to progression in metastatic renal cancer patients treated with targeted therapies
    Nathan, Paul D.
    Vinayan, Anup
    Stott, David
    Juttla, Jaspal
    Goh, Vicky
    CANCER BIOLOGY & THERAPY, 2010, 9 (01) : 15 - 19
  • [46] RECIST 1.1 versus mRECIST for assessment of tumour response to molecular targeted therapies and disease outcomes in patients with hepatocellular carcinoma: a systematic review and meta-analysis
    Yu, Hongli
    Bai, Yuping
    Xie, Xiaoyu
    Feng, Yuemin
    Yang, Yao
    Zhu, Qiang
    BMJ OPEN, 2022, 12 (06): : e052294
  • [47] Systems pathology for building predictive models: The androgen receptor as a prototype biomarker in prostate cancer progression and targeted therapeutic response assessment.
    Donovan, M. J.
    Scher, H.
    Scardino, P.
    Kotsianti, A.
    Cordon-Cardo, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 218S - 218S
  • [48] Peptide receptor radionuclide therapy with 90Y-DOTATATE/90Y-DOTATOC in patients with progressive metastatic neuroendocrine tumours: assessment of response, survival and toxicity
    Vinjamuri, S.
    Gilbert, T. M.
    Banks, M.
    McKane, G.
    Maltby, P.
    Poston, G.
    Weissman, H.
    Palmer, D. H.
    Vora, J.
    Pritchard, D. M.
    Cuthbertson, D. J.
    BRITISH JOURNAL OF CANCER, 2013, 108 (07) : 1440 - 1448
  • [49] Peptide receptor radionuclide therapy with 90Y-DOTATATE/90Y-DOTATOC in patients with progressive metastatic neuroendocrine tumours: assessment of response, survival and toxicity
    S Vinjamuri
    T M Gilbert
    M Banks
    G McKane
    P Maltby
    G Poston
    H Weissman
    D H Palmer
    J Vora
    D M Pritchard
    D J Cuthbertson
    British Journal of Cancer, 2013, 108 : 1440 - 1448
  • [50] Semi-quantitative measurements of chemokine receptor 4-targeted 68Ga-pentixafor PET/CT in response assessment of Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma
    Pan, Qingqing
    Cao, Xinxin
    Luo, Yaping
    Li, Jian
    Li, Fang
    EJNMMI RESEARCH, 2021, 11 (01)
12345